Treatment for Endogenous Cushing's Syndrome
NCT01838551
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Endogenous Cushing's Syndrome
Interventions
DRUG:
Levoketoconazole
Sponsor
Cortendo AB